Constance D. Lehman

Active 1995–2024

Also published as
Constance D Lehman
143
Papers
21,709
Citations
82
h-index
142
i10-index

Citations

Citations per year for Constance D. Lehman1967: 1 citations1983: 1 citations1993: 1 citations1994: 2 citations1995: 3 citations1996: 1 citations1997: 1 citations1998: 1 citations1999: 4 citations2000: 8 citations2001: 13 citations2002: 13 citations2003: 8 citations2004: 6 citations2005: 17 citations2006: 31 citations2007: 75 citations2008: 129 citations2009: 155 citations2010: 160 citations2011: 137 citations2012: 161 citations2013: 172 citations2014: 190 citations2015: 197 citations2016: 197 citations2017: 250 citations2018: 235 citations2019: 774 citations2020: 807 citations2021: 799 citations2022: 646 citations2023: 618 citations2024: 706 citations2025: 375 citations2026: 55 citations1968–1982: no citations, so these years are not shown1984–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,410 citing papers, 33.6% of this breakdownChina: 569 citing papers, 7.9% of this breakdownUnited Kingdom: 406 citing papers, 5.7% of this breakdownItaly: 304 citing papers, 4.2% of this breakdownGermany: 284 citing papers, 4% of this breakdownCanada: 249 citing papers, 3.5% of this breakdownNetherlands: 245 citing papers, 3.4% of this breakdownSouth Korea: 197 citing papers, 2.7% of this breakdownAustralia: 163 citing papers, 2.3% of this breakdownIndia: 154 citing papers, 2.1% of this breakdownFrance: 147 citing papers, 2.1% of this breakdownJapan: 147 citing papers, 2% of this breakdown
0%33.6%Other 26.5%

Fields

  • Medicine59.6%
  • Computer Science18.8%
  • Biochemistry, Genetics and Molecular Biology15.6%
  • Engineering2%
  • Health Professions0.7%
  • Neuroscience0.6%
  • Other2.7%

Topics

  • AI in cancer detection12%
  • Radiomics and Machine Learning in Medical Imaging9.2%
  • MRI in cancer diagnosis7.5%
  • Digital Radiography and Breast Imaging7.4%
  • Breast Cancer Treatment Studies7.4%
  • Global Cancer Incidence and Screening6%
  • Other50.5%

Coauthors

All papers

Open in search
  1. A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction

    Authors: , , , , - Radiology 2019 cited by 735

  2. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection

    Authors: , , , , , - JAMA Internal Medicine 2015 cited by 674

  3. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium

    Authors: , , , , , , , , , , - Radiology 2016 cited by 665

  4. Toward robust mammography-based models for breast cancer risk

    Authors: , , , , , , , , , - Science Translational Medicine 2021 cited by 268

  5. Multi-Institutional Validation of a Mammography-Based Breast Cancer Risk Model

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 187

  6. Standalone AI for Breast Cancer Detection at Screening Digital Mammography and Digital Breast Tomosynthesis: A Systematic Review and Meta-Analysis

    Authors: , , , , , , , , , , , , - Radiology 2023 cited by 173

  7. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography

    Authors: , , , , , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2007 cited by 2,648

  8. Mammographic Breast Density Assessment Using Deep Learning: Clinical Implementation

    Authors: , , , , , , - Radiology 2018 cited by 289

  9. Optimizing risk-based breast cancer screening policies with reinforcement learning

    Authors: , , , , , , , , , , , , - Nature Medicine 2022 cited by 99

  10. Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL

    Authors: , , , , , , , , , , , , , , , - Radiology 2015 cited by 277

  11. A Deep Learning Model to Triage Screening Mammograms: A Simulation Study

    Authors: , , , , - Radiology 2019 cited by 211

  12. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2018 cited by 519

  13. Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL

    Authors: , , , , , , , , , , , , - Radiology 2012 cited by 489

  14. Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Rosen, Despina Kontos, Hiroyuki Abé, Deepa Sheth, Erin P. Crane, Charlotte Dillis, Pulin Sheth, Linda Hovanessian‐Larsen, Dae Hee Bang, Bruce A. Porter, Karen Y. Oh, Neda Jafarian, Alina Tudorica, Bethany L. Niell, Jennifer S. Drukteinis, Mary S. Newell, Michael A. Cohen, Marina E. Giurescu, Elise Berman, Constance D. Lehman, Savannah C. Partridge, Kimberly A. Fitzpatrick, Marisa H. Borders, Wei Yang, Başak E. Doğan, Sally Goudreau, Thomas L. Chenevert, Christina Yau, Angela DeMichele, Don Berry, Laura J. Esserman, Nola M. Hylton - npj Breast Cancer 2020 cited by 82

  15. Identifying Women With Dense Breasts at High Risk for Interval Cancer

    Authors: , , , , , , - Annals of Internal Medicine 2015 cited by 284

  16. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph T. Rabban, Yunni-Yi Chen, Dilip D. Giri, Alfred Au, Nola M. Hylton - Breast Cancer Research and Treatment 2011 cited by 376

  17. Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice

    Authors: , , , , , , , , , , , , , - Annals of Internal Medicine 2016 cited by 201

  18. Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 cited by 441

  19. Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?

    Authors: , , , , , , , - Radiology 2015 cited by 215

  20. Relationship of established risk factors with breast cancer subtypes

    Authors: , , , , , , , , , , , , , - Cancer Medicine 2021 cited by 108

  21. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk

    Authors: , , , , , , , , - JAMA Internal Medicine 2019 cited by 108

  22. Deep Learning vs Traditional Breast Cancer Risk Models to Support Risk-Based Mammography Screening

    Authors: , , , , , , - JNCI Journal of the National Cancer Institute 2022 cited by 53

  23. External Validation of a Deep Learning Model for Predicting Mammographic Breast Density in Routine Clinical Practice

    Authors: , , , , - Academic Radiology 2020 cited by 41

  24. MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2007 cited by 936